Evidence of bias in studies of influenza vaccine effectiveness in elderly patients

Journal of Infectious Diseases

Volumn 201, Issue 2, 2010, Pages 186-189

  Baxter, Roger ^a   Lee, Janelle ^b   Fireman, Bruce ^a  

^a Pediatric Vaccine Study Center   (United States)

^b DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GERIATRIC PATIENT; HEALTH STATUS; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; AGE; EPIDEMIOLOGY; IMMUNOLOGY; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CALIFORNIA; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SELECTION BIAS;

EID: 75649130832     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/649568     Document Type: Article

References (14)

1. 1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186. (Pubitemid 36068705)
2. Mullooly JP, Bridges CB, Thompson WW, et al. Influenza- and RSVassociated hospitalizations among adults. Vaccine 2007; 25: 846-855.
3. Burney LE. Influenza immunization. Public Health Rep 1960; 75: 944.
4. Davenport FM. Inactivated influenza virus vaccines: past, present, and future. Am Rev Respir Dis 1961; 83: 146-156.
5. 5. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661-1665. (Pubitemid 24359136)
6. Poland GA. If you could halve the mortality rate, would you do it? Clin Infect Dis 2002; 35: 378-380.
7. 7. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357: 1373-1381. (Pubitemid 47535592)
8. 8. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007; 7: 658-666. (Pubitemid 47444564)
9. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006; 35: 337-344.
10. Fireman B, Lee J, Lewis E, Bembom O, Van der Laan M, Baxter R. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol 2009; 170: 650-656.
11. 11. Zhao Y, Ash AS, Ellis RP, et al. Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Med Care 2005; 43: 34-43. (Pubitemid 40137612)
12. 12. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis 2001; 184: 665-670. (Pubitemid 32826416)
13. Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested casecontrol study. Lancet 2008; 372: 398-405.
14. 14. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001; 344: 889-896. (Pubitemid 32224397)